CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial

(2019) Yasmin L. Hurd et al.   AMERICAN JOURNAL OF PSYCHIATRY

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model

(2019) Laura E. Ewing et al.   MOLECULES

Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms

(2019) Gabriela Pandini Silote et al.   JOURNAL OF CHEMICAL NEUROANATOMY

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

(2018) Philip McGuire et al.   AMERICAN JOURNAL OF PSYCHIATRY

Cannabis sativa L. – cultivation and quality of raw material

(2018) Krystyna Żuk-Gołaszewska et al.   Journal of Elementology

Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations

(2018) Radmila Pavlovic et al.   MOLECULES

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

(2018) Kerri A. Schoedel et al.   EPILEPSY & BEHAVIOR

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

(2018) Ila M. Linares et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law

(2017) Alice Mead   EPILEPSY & BEHAVIOR

Labeling Accuracy of Cannabidiol Extracts Sold Online

(2017) Marcel O. Bonn-Miller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabidiol in medical marijuana: Research vistas and potential opportunities

(2017) Carola Rong et al.   PHARMACOLOGICAL RESEARCH

Cannabidiol: State of the art and new challenges for therapeutic applications

(2017) Simona Pisanti et al.   PHARMACOLOGY & THERAPEUTICS

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

(2017) Antonio W. Zuardi et al.   Frontiers in Pharmacology

Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes

(2016) Oier Aizpurua-Olaizola et al.   JOURNAL OF NATURAL PRODUCTS

Cannabidiol, neuroprotection and neuropsychiatric disorders

(2016) Alline C. Campos et al.   PHARMACOLOGICAL RESEARCH

Prevalence, Adverse Events, and Factors Associated with Dietary Supplement and Nutritional Supplement Use by US Navy and Marine Corps Personnel

(2016) Joseph J. Knapik et al.   Journal of the Academy of Nutrition and Dietetics

Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes

(2016) Michelle R. Peace et al.   Frontiers in Pharmacology

Too Little, Too Late: Ineffective Regulation of Dietary Supplements in the United States

(2015) Ranjani R. Starr   AMERICAN JOURNAL OF PUBLIC HEALTH

A potted history

(2015) Stephanie Pain   NATURE

Presence of Banned Drugs in Dietary Supplements Following FDA Recalls

(2014) Pieter A. Cohen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Physician–patient communication about dietary supplements

(2013) Derjung M. Tarn et al.   PATIENT EDUCATION AND COUNSELING

Negotiating complementary and alternative medicine use in primary care visits with older patients

(2012) Christopher J. Koenig et al.   PATIENT EDUCATION AND COUNSELING

Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety

(2011) Satoshi Yamaori et al.   LIFE SCIENCES

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY